TLR9 anticorps (N-Term)
Aperçu rapide pour TLR9 anticorps (N-Term) (ABIN2224864)
Antigène
Voir toutes TLR9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 205-235, N-Term
-
Séquence
- SLKYNNLTVV PRNLPSSLEY LLLSYNRIVK L
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- CD289 (TLR9)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to SLKYNNLTVVPRNLPSSLEYLLLSYNRIVKL aa205-235 of human CD289 at N-terminal.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- TLR9 (Toll-Like Receptor 9 (TLR9))
-
Autre désignation
- CD289
-
Pathways
- Signalisation TLR, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades
Antigène
-